Date Field | Doc. No. | Description (Pages) |
---|
Sep 8, 2015 | 23 | MOTION of Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc. to terminate appeal through Dismissal. [Consent: unopposed]. Service: 09/08/2015 by email. [270113] [Gary Rubman] [Entered: 09/08/2015 10:09 AM] (5) |
Sep 8, 2015 | 24 | ORDER granting motion to terminate appeal [23] filed by Appellants Aktiebolaget Hassle, Astrazeneca AB, AstraZeneca LP, KBI, Inc. and KBI-E Inc.; issuing mandate. Service as of this date by Clerk of Court. [270173] [FMS] [Entered: 09/08/2015 11:29 AM] (2) |
Aug 17, 2015 | 17 | Entry of appearance for Einar Stole as of counsel for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc.. Service: 08/17/2015 by email. [264935] [Gary Rubman] [Entered: 08/17/2015 04:58 PM] (2) |
Aug 17, 2015 | 18 | Entry of appearance for Brianne Bharkhda as of counsel for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc.. Service: 08/17/2015 by email. [264936] [Gary Rubman] [Entered: 08/17/2015 05:00 PM] (2) |
Aug 17, 2015 | 19 | Entry of appearance for Paul B. Gaffney as of counsel for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc.. Service: 08/17/2015 by email. [264937] [Gary Rubman] [Entered: 08/17/2015 05:01 PM] (2) |
Aug 17, 2015 | 20 | Entry of appearance for Stanley E. Fisher as of counsel for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc.. Service: 08/17/2015 by email. [264938] [Gary Rubman] [Entered: 08/17/2015 05:03 PM] (2) |
Aug 17, 2015 | 21 | Docketing Statement for the Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc.. Service: 08/17/2015 by email. [264940] [Gary Rubman] [Entered: 08/17/2015 05:05 PM] (4) |
Aug 17, 2015 | 22 | Docketing Statement for the Appellees Mylan Laboratories Limited and Mylan, Inc.. Service: 08/17/2015 by email. [264985] [Dan Bagatell] [Entered: 08/17/2015 10:47 PM] (3) |
Aug 3, 2015 | 1 | Appeal docketed. [261357] Entry of Appearance due 08/17/2015. Certificate of Interest is due on 08/17/2015. Docketing Statement due 08/17/2015. Certified List due on 09/14/2015. [SJ] [Entered: 08/03/2015 10:14 AM] (1) |
Aug 3, 2015 | 2 | MOTION of Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc. for temporary injunction. Response/Opposition is due 08/17/2015 [Consent: opposed]. Service: 08/02/2015 by US mail. [261360] [SJ] [Entered: 08/03/2015 10:23 AM] (112) |
Aug 3, 2015 | 3 | Sealed or confidential document received [Confidential Rule 8 Motion & Exhibits] (corresponding to Doc No. [2]) for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc. Service: 08/02/2015 by US mail. [261365] [SJ] [Entered: 08/03/2015 10:28 AM] (0) |
Aug 3, 2015 | 4 | RESPONSE of Appellees Mylan Laboratories Limited and Mylan, Inc. to the motion for temporary injunction pending appeal [2] filed by Appellants Aktiebolaget Hassle, Astrazeneca AB, AstraZeneca LP, KBI, Inc. and KBI-E Inc. in 15-1889. Service: 08/03/2015 by US mail. [261370]--[Edited 08/03/2015 by SJ to attach public exhibits] [SJ] [Entered: 08/03/2015 10:39 AM] (44) |
Aug 3, 2015 | 5 | Sealed or confidential document received [Confidential Opposition to Rule 8 Motion] (corresponding to Doc No. [4]) for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261372] [SJ] [Entered: 08/03/2015 10:40 AM] (0) |
Aug 3, 2015 | 6 | Sealed or confidential document received [Exhibits to Opposition] (corresponding to Doc No. [5]), (corresponding to Doc No. [4]) for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261404] [SJ] [Entered: 08/03/2015 11:27 AM] (0) |
Aug 3, 2015 | 7 | Letter from Appellees Mylan Laboratories Limited and Mylan, Inc. Federal Rule of Apeelate Procedure 28(j). Service: 08/03/2015 by email. [261446] [Shannon Bloodworth] [Entered: 08/03/2015 12:36 PM] (1) |
Aug 3, 2015 | 8 | Entry of appearance for Gary M. Rubman as principal counsel for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc. Service: 08/02/2015 by US mail. [261453] [SJ] [Entered: 08/03/2015 12:47 PM] (2) |
Aug 3, 2015 | 9 | Entry of appearance for Shannon M. Bloodworth as principal counsel for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261454] [SJ] [Entered: 08/03/2015 12:48 PM] (2) |
Aug 3, 2015 | 10 | Entry of appearance for David L. Anstaett as of counsel for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261455] [SJ] [Entered: 08/03/2015 12:49 PM] (2) |
Aug 3, 2015 | 11 | Sealed or confidential document received [Reply in Suppport of Motion for Injunction Pending Appeal] (corresponding to Doc No. [4]) for Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc.. Service: 08/03/2015 by email. [261456] [Gary Rubman] [Entered: 08/03/2015 12:49 PM] (0) |
Aug 3, 2015 | 12 | Entry of appearance for Dan L. Bagatell as of counsel for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261457] [SJ] [Entered: 08/03/2015 12:51 PM] (2) |
Aug 3, 2015 | 13 | Entry of appearance for Autumn N. Nero as of counsel for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261458] [SJ] [Entered: 08/03/2015 12:52 PM] (2) |
Aug 3, 2015 | 14 | Entry of appearance for Brandon M. White as of counsel for Appellees Mylan Laboratories Limited and Mylan, Inc. Service: 08/03/2015 by US mail. [261460] [SJ] [Entered: 08/03/2015 12:56 PM] (2) |
Aug 3, 2015 | 15 | RESPONSE of Appellants Aktiebolaget Hassle, AstraZeneca LP, Astrazeneca AB, KBI, Inc. and KBI-E Inc. to the confidential document [5] filed by Appellees Mylan, Inc. and Mylan Laboratories Limited in 15-1889. Service: 08/03/2015 by email. [261464] [Gary Rubman] [Entered: 08/03/2015 01:12 PM] (46) |
Aug 3, 2015 | 16 | ORDER filed denying [2] motion for temporary injunction pending appeal filed by Aktiebolaget Hassle, Astrazeneca AB, AstraZeneca LP, KBI, Inc. and KBI-E Inc. Service: 08/03/2015 by clerk. [261595] [LMS] [Entered: 08/03/2015 04:21 PM] (2) |